Moreover, Kaplan-Meier plots of the probability of 3-month survival rates suggest that the overall mortality was lower in patients receiving 40 mg enoxaparin than those receiving placebo, although differences in mortality rates between the three groups did not reach statistical significance.
← all excerpts
An update on prevention of venous thromboembolism in hospitalized acutely ill medical patients.
2
—
—
The sentences
showed a trend towards better efficacy than UFH, t.i.d.